Connection

Susan Dorman to Pharmacogenomic Testing

Back to Details
This is a "connection" page, showing publications Susan Dorman has written about Pharmacogenomic Testing.
Susan Dorman
Connection Strength
0.041
Pharmacogenomic Testing
  1. A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine. Antimicrob Agents Chemother. 2019 04; 63(4).
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.